Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 516-524

  Avril, Stefanie ^a   Hahn, Ellen ^a   Specht, Katja ^a   Hauptmann, Steffen ^b   Höss, Cornelia ^c   Kiechle, Marion ^a   Höfler, Heinz ^a   Schmalfeldt, Barbara ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Krankenhaus Duren gem GmbH   (Germany)

^c Kreisklinik Ebersberg ^*  (Germany)

Author keywords

Clinical outcome; Histopathology; Ovarian borderline tumor; Recurrence; Risk factors

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PROTEIN P53;

ADULT; ARTICLE; BILATERAL SALPINGOOOPHORECTOMY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FERTILITY CONSERVING SURGERY; FOLLOW UP; GENE MUTATION; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY BORDERLINE TUMOR; OVARY CANCER; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SALPINGOOOPHORECTOMY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84868515522     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.027     Document Type: Article

References (41)

1. S.G. Silverberg, D.A. Bell, R.J. Kurman, J.D. Seidman, J. Prat, and B.M. Ronnett Borderline ovarian tumors: key points and workshop summary Hum Pathol 35 8 2004 910 917 [Epub 2004/08/07]
2. International Federation of Gynecology, and F. Obstetrics Classification and staging of malignant tumours in the female pelvis Acta Obstet Gynecol Scand 50 1 1971 1 7 [Epub 1971/01/01]
3. S.S. Serov, R.E. Scully, and L.H. Sobin Histological typing of ovarian tumors 1973 Springer Berlin Heidelberg New York for WHO, Geneva
4. F.A. Tavassoli, and P. Devilee Pathology and genetics of tumours of the breast and female genital organs 2003 IARC Press Lyon
5. J.D. Seidman, R.A. Soslow, R. Vang, J.J. Berman, M.H. Stoler, and M.E. Sherman Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images Hum Pathol 35 8 2004 918 933 [Epub 2004/08/07]
6. K.R. Lee, and R.E. Scully Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei' Am J Surg Pathol 24 11 2000 1447 1464 [Epub 2000/11/15]
7. B.M. Ronnett, A. Kajdacsy-Balla, C.B. Gilks, M.J. Merino, E. Silva, and B.A. Werness Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior Hum Pathol 35 8 2004 949 960 [Epub 2004/08/07]
8. D.A. Bell, T.A. Longacre, J. Prat, E.C. Kohn, R.A. Soslow, and L.H. Ellenson Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives Hum Pathol 35 8 2004 934 948 [Epub 2004/08/07]
9. J.D. Seidman, and R.J. Kurman Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators Hum Pathol 31 5 2000 539 557 [Epub 2000/06/03]
10. M. Shih Ie, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 5 2004 1511 1518 [Epub 2004/04/28]
11. G. Singer, R. Stohr, L. Cope, R. Dehari, A. Hartmann, and D.F. Cao Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation Am J Surg Pathol 29 2 2005 218 224 [Epub 2005/01/13]
12. R.J. Kurman, and M. Shih Ie Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 2 2008 151 160 [Epub 2008/03/05]
13. R.J. Kurman, and M. Shih Ie The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 3 2010 433 443 [Epub 2010/02/16]
14. A. Malpica, M.T. Deavers, K. Lu, D.C. Bodurka, E.N. Atkinson, and D.M. Gershenson Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 4 2004 496 504 [Epub 2004/04/17]
15. V. Auner, G. Kriegshauser, D. Tong, R. Horvat, A. Reinthaller, and A. Mustea KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay BMC Cancer 9 2009 111 [Epub 2009/04/11]
16. S.C. Mok, D.A. Bell, R.C. Knapp, P.M. Fishbaugh, W.R. Welch, and M.G. Muto Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy Cancer Res 53 7 1993 1489 1492 [Epub 1993/04/01]
17. G. Singer, R. Oldt 3rd, Y. Cohen, B.G. Wang, D. Sidransky, and R.J. Kurman Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma J Natl Cancer Inst 95 6 2003 484 486 [Epub 2003/03/20]
18. M.F. Kohler, J.R. Marks, R.W. Wiseman, I.J. Jacobs, A.M. Davidoff, and D.L. Clarke-Pearson Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer J Natl Cancer Inst 85 18 1993 1513 1519 [Epub 1993/09/15]
19. R.T. Burks, M.E. Sherman, and R.J. Kurman Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors Am J Surg Pathol 20 11 1996 1319 1330 [Epub 1996/11/01]
20. J.D. Seidman, and R.J. Kurman Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases Am J Surg Pathol 20 11 1996 1331 1345 [Epub 1996/11/01]
21. F.A. Tavassoli Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion) Mod Pathol 1 6 1988 407 414 [Epub 1988/11/01]
22. D.A. Bell, and R.E. Scully Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases Hum Pathol 21 4 1990 397 403 [Epub 1990/04/01]
23. D. Mayr, A. Hirschmann, U. Lohrs, and J. Diebold KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants Gynecol Oncol 103 3 2006 883 887 [Epub 2006/06/30]
24. A. Yemelyanova, R. Vang, M. Kshirsagar, D. Lu, M.A. Marks, and M. Shih Ie Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis Mod Pathol 24 9 2011 1248 1253 [Epub 2011/05/10]
25. L.M. Kmet, L.S. Cook, and A.M. Magliocco A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors Cancer 97 2 Jan 2003 15 389 404
26. I. Cadron, K. Leunen, T. Van Gorp, F. Amant, P. Neven, and I. Vergote Management of borderline ovarian neoplasms J Clin Oncol 25 20 2007 2928 2937 [Epub 2007/07/10]
27. A. Du Bois, N. Ewald-Riegler, O. Du Bois, and P. Harter Borderlinetumoren des Ovars - eine systematische Übersicht Borderline tumors of the ovary - a systematic review Geburtshilfe Frauenheilkd 69 2009 1 27
28. J. Ren, Z. Peng, and K. Yang A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors Gynecol Oncol 110 2 2008 162 167 [Epub 2008/05/23]
29. E.G. Silva, D.M. Gershenson, A. Malpica, and M. Deavers The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent Am J Surg Pathol 30 11 2006 1367 1371 [Epub 2006/10/26]
30. G. Zanetta, S. Rota, S. Chiari, C. Bonazzi, G. Bratina, and C. Mangioni Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study J Clin Oncol 19 10 2001 2658 2664 [Epub 2001/05/16]
31. E.G. Silva, C. Tornos, Z. Zhuang, M.J. Merino, and D.M. Gershenson Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential Int J Gynecol Pathol 17 1 1998 1 6 [Epub 1998/02/25]
32. M.A. Crispens, D. Bodurka, M. Deavers, K. Lu, E.G. Silva, and D.M. Gershenson Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential Obstet Gynecol 99 1 2002 3 10 [Epub 2002/01/05]
33. J. Prat, and M. De Nictolis Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion Am J Surg Pathol 26 9 2002 1111 1128 [Epub 2002/09/10]
34. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, K.R. Kim, and Y.T. Kim Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol 123 3 2011 511 516 [Epub 2011/09/16]
35. J.H. Eichhorn, D.A. Bell, R.H. Young, and R.E. Scully Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns Am J Surg Pathol 23 4 1999 397 409 [Epub 1999/04/13]
36. J.K. McKenney, B.L. Balzer, and T.A. Longacre Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion Am J Surg Pathol 30 10 2006 1209 1221 [Epub 2006/09/27]
37. G.H. Segal, and W.R. Hart Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal implants Am J Surg Pathol 16 6 1992 577 583 [Epub 1992/06/01]
38. P. Morice, S. Camatte, A. Rey, D. Atallah, C. Lhomme, and P. Pautier Prognostic factors for patients with advanced stage serous borderline tumours of the ovary Ann Oncol 14 4 2003 592 598 [Epub 2003/03/22]
39. D.M. Gershenson, E.G. Silva, L. Levy, T.W. Burke, J.K. Wolf, and C. Tornos Ovarian serous borderline tumors with invasive peritoneal implants Cancer 82 6 1998 1096 1103 [Epub 1998/03/20]
40. K.K. Shih, Q. Zhou, J. Huh, J.C. Morgan, A. Iasonos, and C. Aghajanian Risk factors for recurrence of ovarian borderline tumors Gynecol Oncol 120 3 2011 480 484 [Epub 2010/12/15]
41. G. Zanetta, S. Rota, A. Lissoni, A. Meni, G. Brancatelli, and A. Buda Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors Gynecol Oncol 81 1 2001 63 66 [Epub 2001/03/30]